Literature DB >> 21252481

Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma.

YingLi Lin1, Guang Sun, XiaoQiang Liu, YeGang Chen, ChunTing Zhang.   

Abstract

OBJECTIVE: To investigate the clinical significance of T-cadherin (T-cad) tissue expression in patients with bladder transitional cell carcinoma (TCC).
MATERIALS AND METHODS: T-cad expression in 113 bladder TCC specimens and 37 normal controls were examined by immunohistochemical staining, and the results were correlated with clinicopathologic parameters. The χ(2) test, Kaplan-Meier survival analysis, log-rank test, and Cox proportional hazard model were used for statistical analysis.
RESULTS: T-cad expression in bladder TCC samples was lower than in the controls. Decreased T-cad expression was correlated with advanced stage (p = 0.0027), high grade (p = 0.0078), large tumor size (p = 0.0262), and tumor relapse (p = 0.0293), but no association was found among T-cad expression and age (p = 0.1265), gender (p = 0.4236), tumor number (p = 0.0595) or tumor shape (p = 0.1779). Moreover, decreased T-cad expression was significantly associated with poor overall survival (p = 0.0168), even though it is not an independent prognostic marker (p = 0.2005).
CONCLUSIONS: Decreased T-cad expression in tumor tissues is closely associated with malignancy in bladder TCC.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252481     DOI: 10.1159/000322962

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  T-cadherin is associated with prognosis in triple-negative breast cancer.

Authors:  De-Di Kong; Mei-Hong Wang; Jie Yang; Liang Li; Wei Wang; Shi-Bing Wang; Yan-Zhen Zhou
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

2.  Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling.

Authors:  Dengfei Xu; Hui Yuan; Zihong Meng; Chunmei Yang; Zefang Li; Mengge Li; Zhigang Zhang; Yu Gan; Hong Tu
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

3.  Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.

Authors:  Ying-Li Lin; Pei-Gen Xie; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-09-04

4.  Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.

Authors:  Ying-Li Lin; Yan-Ling Wang; Xing-Li Fu; Wen-Ping Li; Yu-Hao Wang; Jian-Guo Ma
Journal:  Oncotarget       Date:  2016-05-10

5.  Mex3a expression and survival analysis of bladder urothelial carcinoma.

Authors:  Jing-Wen Shi; Ying Huang
Journal:  Oncotarget       Date:  2017-06-07

6.  Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.

Authors:  Agnieszka Latosinska; Marika Mokou; Manousos Makridakis; William Mullen; Jerome Zoidakis; Vasiliki Lygirou; Maria Frantzi; Ioannis Katafigiotis; Konstantinos Stravodimos; Marie C Hupe; Maciej Dobrzynski; Walter Kolch; Axel S Merseburger; Harald Mischak; Maria G Roubelakis; Antonia Vlahou
Journal:  Oncotarget       Date:  2017-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.